NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
Covered in this story
What has happened since
- Charles River Laboratories is up 5.7% since this was published, 21 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Charles River Laboratories
- Jefferies: $295 → $340 by Sep 2027 · Buy via Investing.com UK
- JPMorgan: $266 → $310 by Aug 2027 · Overweight via Investing.com
- Evercore ISI: $261 → $300 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Charles River Laboratories →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.